Patient Age and Comorbidity Are Major Determinants of Adjuvant Chemotherapy Use for Stage III Colon Cancer in Routine Clinical Practice
- 20 September 2008
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (27) , 4516-4517
- https://doi.org/10.1200/jco.2008.18.7443
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Adjuvant Chemotherapy for Stage III Colon Cancer: Do Physicians Agree About the Importance of Patient Age and Comorbidity?Journal of Clinical Oncology, 2008
- Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide SurveyJournal of Oncology Practice, 2008
- Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trialsAnnals of Oncology, 2004
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001